172@29@16@54!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_ANNOUNCEMENT&priceinter=1&frommc=1!~!|commonstore|commonfiles|moneycontrol_header.php
Moneycontrol
SENSEX NIFTY
you are here:

RPG Life Sciences Ltd.

BSE: 532983 | NSE: RPGLIFE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE105J01010 | SECTOR: Pharmaceuticals

BSE Live

Aug 13, 16:00
377.45 -0.40 (-0.11%)
Volume
AVERAGE VOLUME
5-Day
26,696
10-Day
29,178
30-Day
19,265
10,202
  • Prev. Close

    377.85

  • Open Price

    380.25

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Aug 13, 15:58
378.00 0.25 (0.07%)
Volume
AVERAGE VOLUME
5-Day
231,114
10-Day
334,627
30-Day
206,659
95,362
  • Prev. Close

    377.75

  • Open Price

    378.50

  • Bid Price (Qty.)

    378.00 (314)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON RPG Life

  • Aug 01, 2020 18:44 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Newspaper Publication

    In terms of the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the newspaper publications with respect to Unaudited Financial Results for the quarter ended June 30, 2020. Kindly take this information on record.

  • Jul 31, 2020 21:46 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    Please find enclosed herewith a copy of press release with respect to Unaudited Financial Results of the Company for the quarter ended June 30, 2020. Kindly take the above on record.

  • Jul 31, 2020 18:11 Source: BSE

    RPG Life Sciences - Authorised Kmps To Determine Materiality Of Events/Information

    Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board at its meeting held on July 31, 2020 has authorised the following Key Managerial Personnel (KMP) of the Company jointly for the purpose of determining materiality of events/information with effect from August 3, 2020: Sr. No. Name Designation 1 Mr. Yugal Sikri Managing Director 2 Mr. Vishal Shah Chief Financial Officer For making disclosures to Stock Exchanges, the following KMPs are severally authorised; Sr. No. Name Designation 1 Mr. Yugal Sikri Managing Director 2 Mr. Vishal Shah Chief Financial Officer 3 Mr. Rajesh Shirambekar Head - Legal and Company Secretary The single point contact of the aforesaid KMP is as under: RPG Life Sciences Limited Registered Office :RPG House, 463, Dr. Annie Besant Road, Worli, Mumbai - 400030 Phone:022-24981650 Email:rajesh.shirambekar@rpgls.com Kindly take the same on your record.

  • Jul 31, 2020 17:50 Source: BSE

    RPG Life Sciences - Unaudited Financial Result For The Quarter Ended June 30, 2020

    Pursuant to Regulation 33 Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter ended June 30, 2020 which were approved by the Board of Directors of the Company, at its meeting held on July 31, 2020 along with Limited Review Report issued by the Statutory Auditors of the Company. The meeting commenced at 03:00 p.m. and concluded at 05:30 p.m.

  • Jul 31, 2020 17:45 Source: BSE

    RPG Life Sciences - Outcome Of Board Meeting Held On July 31, 2020

    In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on July 31, 2020, inter alia, has: 1. considered and approved the Unaudited Financial Results of the Company for the quarter ended June 30, 2020 along with Limited Review Report of the Statutory Auditors thereon. 2. approved appointment of Mr. Vishal Shah as Chief Financial Officer of the Company with effect from August 3, 2020, based on recommendation of Nomination and Remuneration Committee and Audit Committee. 3. approved continuation of Mr. Mahesh Narayanaswamy as Vice President - Finance up to October 31, 2020. Profile of Mr. Vishal Shah is enclosed herewith as ''''Annexure A''''. It may be noted that he is not related to any other Director or Key Managerial Personnel of the Company. The meeting commenced at 03:00 p.m. and concluded at 05:30 p.m.

  • Jul 30, 2020 14:33 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the copy of Notice of 13th Annual General Meeting published in newspaper on July 30, 2020 in Business Standard (English) and Mumbai-Lakshadeep (Marathi), as intimation of completion of dispatch of Notice of AGM, and availability of remote e-voting facility. Request you to kindly take the same on record.

  • Jul 28, 2020 19:17 Source: BSE

    RPG Life Sciences - Thirteenth Annual General Meeting ('AGM') Of The Members Of The Company Will Be Held On Thursday, August 20, 2020 At 3.00 Pm (IST) Through Video Conferencing (VC) / Other Audio Visual Means (OAVM)

    This is to inform you that the Thirteenth Annual General Meeting (''AGM'') of the Members of the Company will be held on Thursday, August 20, 2020 at 3.00 pm (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM), in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India, inter alia, to transact the businesses stated in the Notice convening the said AGM. Pursuant to Regulation 34(1) and Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial year 2019-20 along with the Notice of AGM, which is being sent through electronic mode to the Members of the Company, whose e-mail IDs are registered with Depositories/ Company/ Registrar and Share Transfer Agent.

  • Jul 28, 2020 19:07 Source: BSE

    RPG Life Sciences - Reg. 34 (1) Annual Report

    This is to inform you that the 13th Annual General Meeting (''AGM'') of the Members of the Company will be held on Thursday, August 20, 2020 at 3.00 pm (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM), in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India, inter alia, to transact the businesses stated in the Notice convening the said AGM. Pursuant to Regulation 34(1) and Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial year 2019-20 along with the Notice of AGM. Request you to kindly take the same on records.

  • Jul 27, 2020 19:12 Source: BSE

    RPG Life Sciences - Announcement under Regulation 30 (LODR)-Dividend Updates

    With reference to our letter dated April 15, 2020 on the captioned subject, informing the restrictions on dispatch of Dividend Warrants/ Demand Drafts to such other shareholders who could not be paid electronically due to absence of their relevant bank details, we would like further update that, upon resumption of postal services, the Company has completed the dispatch of the Dividend Warrants/Demand Drafts to such shareholders. Kindly take the above on record.

  • Jul 24, 2020 16:26 Source: BSE

    RPG Life Sciences - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2020

    RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2020 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday, July 31, 2020, inter-alia, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2020. Further, pursuant to the ''Code of Fair Disclosure (including Determination of Legitimate Purpose), Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Person(s)'' of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, the Trading Window Close Period has commenced from July 1, 2020 and will end 48 hours after the results are made public on July 31, 2020. Kindly take this information on record.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Jul 31, 2020
Remark : Quarterly Results